Trial Profile
A comparative study to evaluate the efficacy and safety of Biosimilar Filgrastim in patients after autologus stem cell transplant
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Sep 2016
Price :
$35
*
At a glance
- Drugs Filgrastim (Primary) ; Lenograstim; Pegfilgrastim
- Indications Haematological malignancies; Hodgkin's disease; Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- 13 Sep 2016 New trial record